Pellagrous encephalopathy presenting as alcohol withdrawal delirium: A case series and literature review
نویسندگان
چکیده
BACKGROUND Alcohol withdrawal delirium (AWD) is associated with significant morbidity and mortality. Pellagra (niacin deficiency) can be a cause of delirium during alcohol withdrawal that may often be overlooked. OBJECTIVES We present a three-patient case series of pellagrous encephalopathy (delirium due to pellagra) presenting as AWD. METHODS We provide a brief review of pellagra's history, data on pellagra's epidemiology, and discuss pellagra's various manifestations, particularly as related to alcohol withdrawal. We conclude by providing a review of existing guidelines on the management of alcohol withdrawal, highlighting that they do not include pellagrous encephalopathy in the differential diagnosis for AWD. RESULTS Though pellagra has been historically described as the triad of dementia, dermatitis, and diarrhea, it seldom presents with all three findings. The neurocognitive disturbance associated with pellagra is better characterized by delirium rather than dementia, and pellagra may present as an isolated delirium without any other aspects of the triad. DISCUSSION Although endemic pellagra is virtually eradicated in Western countries, it continues to present as pellagrous encephalopathy in patients with risk factors for malnutrition such as chronic alcohol intake, homelessness, or AIDS. It may often be mistaken for AWD. Whenever pellagra is suspected, treatment with oral nicotinamide (100 mg three times daily for 3-4 weeks) prior to laboratory confirmation is recommended as an inexpensive, safe, and potentially life-saving intervention.
منابع مشابه
Rapid Death Due to Alcohol Withdrawal Syndrome: Case Report and Review of Literature
Background: Alcohol withdrawal syndrome (AWS) is one of the most serious complications associated with chronic alcoholism. Sudden deaths are not uncommon in AWS. In severe stages of AWS, delirium tremens (DT) occurs, which is characterized with agitation, global confusion, disorientation, visual and auditory hallucinations in addition to autonomic hyperactivity. Case report: A 30-year old man, ...
متن کاملTreatment of Severe Alcohol Withdrawal.
OBJECTIVE Approximately 50% of patients with alcohol dependence experience alcohol withdrawal. Severe alcohol withdrawal is characterized by seizures and/or delirium tremens, often refractory to standard doses of benzodiazepines, and requires aggressive treatment. This review aims to summarize the literature pertaining to the pharmacotherapy of severe alcohol withdrawal. DATA SOURCES PubMed (...
متن کامل2. Mayo-smith Mf: Pharmacological Management of Alcohol Withdrawal. a Meta-analysis and Evidence-based Practice Guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal
Are benzodiazepines and anticonvulsants effective for patient with alcohol withdrawal symptoms?(Are anticonvulsants more effective than benzodiazepines?) P: alcohol withdrawal I: benzodiazepines and anticonvulsants C: placebo or active placebo O: prevent or relief alcohol symptoms (ex: delirium, seizure) , prevent re-intake alcohol 關鍵字(Key words): (alcohol withdrawal and benzodiazepine) (alcoho...
متن کاملThe use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
BACKGROUND Chronic alcohol consumption is a prevalent issue. Healthcare professionals often discover their patient has an alcohol consumption issue when they are admitted to the hospital and no longer have access to alcohol. The global standard for treating alcohol withdrawal syndrome (AWS) symptoms are benzodiazepines; however this therapy is often inadequate to control symptoms of delirium in...
متن کاملReview: sedative-hypnotic agents reduce mortality and duration of delirium in the alcohol withdrawal syndrome.
and commentary also appear in ACP Journal Club. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . For correspondence: Dr M F Mayo-Smith, Veterans Administration Medical Center, Manchester, NH, USA. [email protected] Sources of funding: American Society of Addiction Medicine and Stepping Stones Foundation. Commen...
متن کامل